Formulation and Drug Delivery

FDA Approves New Generic Valsartan

March 12, 2019

The agency prioritized the review of the generic angiotensin II receptor blocker to help relieve the shortage of valsartan due to recent recalls.

Biotech Receives EUR 1.5 Million in Funding to Develop a New Class of Antibiotics

March 08, 2019

Procarta Biosystems has received investment from Novo Holdings REPAIR Impact Fund to the tune of €1.5 million, which will be used to develop a new class of antibiotics to tackle AMR.

FDA Takes Steps to Refine Biosimilar Naming Convention

March 08, 2019

FDA Commissioner Gottlieb released a statement on the agency’s efforts to refine the naming convention for biosimilars to balance competition and to help ensure patient safety.

FDA Approves New Treatment for Depression

March 07, 2019

Janssen’s Spravato (esketamine) gains approval with restricted distribution guidelines.

Latest ARB Recall Triggered by New Impurity

March 07, 2019

Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid.

GeoVax, Leidos Expand Collaboration to Include Malaria Vaccines

March 05, 2019

The companies will use GeoVax’s vaccine technology to develop malaria vaccine candidates.

Biogen to Acquire Gene-Therapy Company Nightstar in $800-Million Deal

March 05, 2019

The acquisition will establish a clinical pipeline for Biogen of gene-therapy candidates in ophthalmology.

Caught in a Conundrum

March 02, 2019

Do patients get what they pay for when they demand cheaper drugs?

Strategic Screening for Solubility Solutions

March 02, 2019

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.

Handle with Care

March 02, 2019

Bio/pharma companies facing new challenges in light of the increasing HPAPI market may benefit from outsourcing.